Saved in:
Bibliographic Details
Main Authors: Brittany P. Rickard, Lauren A. Sapienza‐Lundie, Marta Overchuk, Xianming Tan, Victoria L. Bae‐Jump, Melinda S. Yates, Suzanne E. Fenton, Imran Rizvi
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
Online Access:https://onlinelibrary.wiley.com/doi/10.1111/php.14073
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867002919219363840
author Brittany P. Rickard
Lauren A. Sapienza‐Lundie
Marta Overchuk
Xianming Tan
Victoria L. Bae‐Jump
Melinda S. Yates
Suzanne E. Fenton
Imran Rizvi
author_facet Brittany P. Rickard
Lauren A. Sapienza‐Lundie
Marta Overchuk
Xianming Tan
Victoria L. Bae‐Jump
Melinda S. Yates
Suzanne E. Fenton
Imran Rizvi
Brittany P. Rickard
Lauren A. Sapienza‐Lundie
Marta Overchuk
Xianming Tan
Victoria L. Bae‐Jump
Melinda S. Yates
Suzanne E. Fenton
Imran Rizvi
collection Wiley Open Access
contents Photodynamic priming overcomes platinum resistance from short‐term exposure to select perfluoroalkyl substances in endometrial cancer cell lines Brittany P. Rickard Lauren A. Sapienza‐Lundie Marta Overchuk Xianming Tan Victoria L. Bae‐Jump Melinda S. Yates Suzanne E. Fenton Imran Rizvi Photochemistry and Photobiology AbstractFirst‐line treatment for advanced‐stage or recurrent endometrial cancer consists of platinum‐ and taxane‐based chemotherapy, to which many patients will develop resistance. Determining the factors that contribute to platinum resistance and developing alternate treatment options for patients with advanced‐stage gynecologic malignancies is critical to improving survival outcomes. Recently, we published the first study evaluating the contribution of perfluoroalkyl substances (PFAS) exposure to platinum resistance in endometrial cancer cell lines and found that select PFAS induce carboplatin resistance, potentially by dysregulating mitochondrial function. The present study expands upon those findings by examining the efficacy of photodynamic priming (PDP) in combination with carboplatin to overcome PFAS‐induced platinum resistance. Due to the suspected role of mitochondrial dysfunction in platinum resistance, two clinically approved photosensitizers that, in part, localize to mitochondrial membranes or are synthesized in mitochondria were evaluated: benzoporphyrin derivative (BPD) and aminolevulinic acid‐induced protoporphyrin IX (ALA‐PpIX), respectively. Combination of ALA‐PpIX‐mediated PDP + carboplatin resulted in a greater reduction in survival fraction than the same combination with BPD. While PDP with both photosensitizers reduced mitochondrial membrane potential, the reduction was greater with BPD‐PDP than ALA‐PpIX‐PDP. These findings demonstrate that BPD‐PDP and ALA‐PpIX‐PDP in combination with carboplatin can be used to overcome PFAS‐induced platinum resistance in endometrial cancer cells. 10.1111/php.14073 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1111/php.14073
format Artículo Open Access
id wiley_oa_10_1111_php_14073
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Photodynamic priming overcomes platinum resistance from short‐term exposure to select perfluoroalkyl substances in endometrial cancer cell lines
Brittany P. Rickard
Lauren A. Sapienza‐Lundie
Marta Overchuk
Xianming Tan
Victoria L. Bae‐Jump
Melinda S. Yates
Suzanne E. Fenton
Imran Rizvi
Photochemistry and Photobiology
Photodynamic priming overcomes platinum resistance from short‐term exposure to select perfluoroalkyl substances in endometrial cancer cell lines Brittany P. Rickard Lauren A. Sapienza‐Lundie Marta Overchuk Xianming Tan Victoria L. Bae‐Jump Melinda S. Yates Suzanne E. Fenton Imran Rizvi Photochemistry and Photobiology AbstractFirst‐line treatment for advanced‐stage or recurrent endometrial cancer consists of platinum‐ and taxane‐based chemotherapy, to which many patients will develop resistance. Determining the factors that contribute to platinum resistance and developing alternate treatment options for patients with advanced‐stage gynecologic malignancies is critical to improving survival outcomes. Recently, we published the first study evaluating the contribution of perfluoroalkyl substances (PFAS) exposure to platinum resistance in endometrial cancer cell lines and found that select PFAS induce carboplatin resistance, potentially by dysregulating mitochondrial function. The present study expands upon those findings by examining the efficacy of photodynamic priming (PDP) in combination with carboplatin to overcome PFAS‐induced platinum resistance. Due to the suspected role of mitochondrial dysfunction in platinum resistance, two clinically approved photosensitizers that, in part, localize to mitochondrial membranes or are synthesized in mitochondria were evaluated: benzoporphyrin derivative (BPD) and aminolevulinic acid‐induced protoporphyrin IX (ALA‐PpIX), respectively. Combination of ALA‐PpIX‐mediated PDP + carboplatin resulted in a greater reduction in survival fraction than the same combination with BPD. While PDP with both photosensitizers reduced mitochondrial membrane potential, the reduction was greater with BPD‐PDP than ALA‐PpIX‐PDP. These findings demonstrate that BPD‐PDP and ALA‐PpIX‐PDP in combination with carboplatin can be used to overcome PFAS‐induced platinum resistance in endometrial cancer cells. 10.1111/php.14073 http://creativecommons.org/licenses/by/4.0/
title Photodynamic priming overcomes platinum resistance from short‐term exposure to select perfluoroalkyl substances in endometrial cancer cell lines
topic Photochemistry and Photobiology
url https://onlinelibrary.wiley.com/doi/10.1111/php.14073